Kodiak Sciences Inc.
NASDAQ:KOD
9.25 (USD) • At close December 23, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 25.947 | 11.001 | 8.711 | 4.208 | 0.911 | 0.49 | 0.549 | 0.257 |
| Gross Profit
| -25.947 | -11.001 | -8.711 | -4.208 | -0.911 | -0.49 | -0.549 | -0.257 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 206.298 | 267.591 | 217.34 | 107.389 | 37.506 | 18.793 | 22.022 | 14.053 |
| General & Administrative Expenses
| 71.023 | 73.788 | 49.711 | 28.618 | 11.684 | 7.581 | 3.499 | 3.098 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 71.023 | 73.788 | 49.711 | 28.618 | 11.684 | 7.581 | 3.499 | 3.098 |
| Other Expenses
| 0 | 0.503 | -0.215 | 0.034 | 0.265 | -4.071 | -1.23 | 0.025 |
| Operating Expenses
| 277.321 | 341.379 | 267.051 | 136.007 | 49.19 | 26.374 | 25.521 | 17.151 |
| Operating Income
| -277.321 | -341.379 | -267.051 | -136.007 | -49.19 | -26.374 | -25.521 | -17.151 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 16.83 | 7.556 | 0.061 | 2.911 | 1.825 | -15.069 | -2.415 | 0.019 |
| Income Before Tax
| -260.491 | -333.823 | -266.99 | -133.096 | -47.365 | -41.443 | -27.936 | -17.132 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 7.346 | -0.154 | 2.73 | -0.638 | -9.55 | -0.045 | 0.031 |
| Net Income
| -260.491 | -333.823 | -266.99 | -133.096 | -46.727 | -41.443 | -27.936 | -17.132 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -4.97 | -6.39 | -5.16 | -2.91 | -1.23 | -2.77 | -1.05 | -0.65 |
| EPS Diluted
| -4.97 | -6.39 | -5.16 | -2.91 | -1.23 | -2.77 | -1.05 | -0.65 |
| EBITDA
| -259.023 | -322.804 | -258.257 | -128.863 | -46.446 | -35.434 | -26.202 | -16.869 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |